Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnilever Regulatory News (ULVR)

Share Price Information for Unilever (ULVR)

Share Price is delayed by 15 minutes
Get Live Data
4,383.50    -18.00 (-0.41%)
Bid:
4,378.00
Ask:
4,379.00
Spread: 1.00 (0.023%)
Market Cap: £94.92b
ULVR Live PriceLast checked at - London Stock Exchange

Intraday Unilever Share Chart

AGM Statement

2 May 2019 14:06

RNS Number : 9251X
Unilever PLC
02 May 2019
 

UNILEVER PLC

 

ANNUAL GENERAL MEETING

 

ALL RESOLUTIONS APPROVED

 

 

Unilever PLC shareholders today approved all resolutions put to the 2019 Annual General Meeting in Leatherhead. Voting was by poll on each resolution and the results are set out below.

 

 

BOARD APPOINTMENTS

 

The following directors stood for re-election and were duly re-elected by the shareholders of Unilever PLC:

Nils Andersen, Laura Cha, Vittorio Colao, Marijn Dekkers, Judith Hartmann, Andrea Jung, Mary Ma, Strive Masiyiwa, Youngme Moon, Graeme Pitkethly, John Rishton and Feike Sijbesma.

 

Alan Jope and Susan Kilsby were proposed for election for the first time and were duly elected by the shareholders of Unilever PLC. Susan Kilsby's appointment will take effect from 1 August 2019.

 

 

POLL RESULTS - ANNUAL GENERAL MEETING 2 MAY 2019

 

 

TOTAL VOTES FOR

%

TOTAL VOTES AGAINST

%

TOTAL VOTES CAST

% OF SHARE CAPITAL VALIDLY CAST VOTED FOR AND AGAINST

VOTES WITHHELD

1. To receive the Report and Accounts for the year ended 31 December 2018

858,831,215

99.34

5,739,348

0.66

864,570,563

73.99%

1,914,082

2. To approve the Directors' Remuneration Report

818,402,509

95.62

37,494,360

4.38

855,896,869

73.25%

10,581,922

3. To re-elect Mr N S Andersen as a Director

857,679,790

99.76

2,072,349

0.24

859,752,139

73.58%

6,733,700

4. To re-elect Mrs L M Cha as a Director

861,834,871

99.63

3,232,140

0.37

865,067,011

74.03%

1,418,830

5.To re-elect Mr V Colao as a Director

835,784,082

98.11

16,126,019

1.89

851,910,101

72.90%

14,575,618

6. To re-elect Dr M Dekkers as a Director

836,388,257

96.69

28,665,243

3.31

865,053,500

74.03%

1,432,239

7.To re-elect Dr J Hartmann as a Director

839,769,945

97.08

25,275,506

2.92

865,045,451

74.03%

1,440,388

8. To re-elect Ms A Jung as a Director

851,049,037

98.44

13,518,783

1.56

864,567,820

73.99%

1,916,848

9. To re-elect Ms M Ma as a Director

855,097,363

98.85

9,979,431

1.15

865,076,794

74.03%

1,409,047

10. To re-elect Mr S Masiyiwa as a Director

863,812,183

99.86

1,210,425

0.14

865,022,608

74.03%

1,458,474

11. To re-elect Professor Y Moon as a Director

823,830,231

95.24

41,209,050

4.76

865,039,281

74.03%

1,446,559

12.To re-elect Mr G Pitkethly as a Director

862,903,261

99.75

2,164,902

0.25

865,068,163

74.03%

1,417,677

13. To re-elect Mr J Rishton as a Director

861,272,884

99.57

3,751,974

0.43

865,024,858

74.03%

1,461,291

14. To re-elect Mr F Sijbesma as a Director

855,703,530

99.52

4,136,808

0.48

859,840,338

73.58%

6,645,902

15. To elect Mr A Jope as a Director

864,230,882

99.90

827,747

0.10

865,058,629

74.03%

1,427,612

16. To elect Mrs S Kilsby as a Director

847,762,740

98.01

17,197,292

1.99

864,960,032

74.02%

1,425,225

17. To reappoint KPMG LLP as Auditors of the Company

863,687,004

99.84

1,404,818

0.16

865,091,822

74.03%

1,394,276

18. To authorise the Directors to fix the remuneration of the Auditor

863,361,265

99.80

1,713,573

0.20

865,074,838

74.03%

1,410,741

19. To authorise Political Donations and Expenditure

855,380,824

99.33

5,785,978

0.67

861,166,802

73.70%

5,308,668

20. To renew the authority to Directors to issue shares

856,934,317

99.04

8,305,531

0.96

865,239,848

74.05%

1,243,624

21. To renew the authority to Directors to disapply pre-emption rights

863,184,976

99.80

1,743,721

0.20

864,928,697

74.02%

1,557,055

22. To renew the authority to Directors to disapply pre-emption rights for the purposes of acquisitions or capital investments

843,552,366

97.52

21,441,372

2.48

864,993,738

74.02%

1,492,863

23. To renew the authority to the Company to purchase its own shares

856,536,699

99.03

8,352,437

0.97

864,889,136

74.02%

1,597,955

24. To shorten the Notice period for General Meetings

797,814,612

92.76

62,237,907

7.24

860,052,519

73.60%

6,430,222

 

 

NOTES:

- The 'For' vote includes votes given at the Chairman's discretion and details of proxy votes cast are included to in the table above.

- The total number of Unilever PLC Ordinary shares with voting rights in issue at 10.30am on Thursday 2 May 2019 was 1,168,530,650. Unilever PLC does not hold any shares in treasury.

 

A 'Vote withheld' is not a vote in law and will not be counted in the calculation of the proportion of the votes 'for' and 'against' a resolution.

 

In accordance with Listing Rule 9.6.2 copies of all the resolutions passed, other than ordinary business, will be submitted to and available for inspection at the National Storage Mechanism and will shortly be available for inspection at: http://www.morningstar.co.uk/uk/NSM. A copy of the resolutions can also be found in the Chairman's Letter and Notice of Meeting which is available on our website: www.unilever.com/AGM

 

 

2 May 2019

 

 

 

Safe Harbour:

 

This announcement may contain forward-looking statements, including 'forward-looking statements' within the meaning of the United States Private Securities Litigation Reform Act of 1995. Words such as 'will', 'aim', 'expects', 'anticipates', 'intends', 'looks', 'believes', 'vision', or the negative of these terms and other similar expressions of future performance or results, and their negatives, are intended to identify such forward-looking statements. These forward-looking statements are based upon current expectations and assumptions regarding anticipated developments and other factors affecting the Unilever Group (the 'Group'). They are not historical facts, nor are they guarantees of future performance.

 

Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. Among other risks and uncertainties, the material or principal factors which could cause actual results to differ materially are: Unilever's global brands not meeting consumer preferences; Unilever's ability to innovate and remain competitive; Unilever's investment choices in its portfolio management; inability to find sustainable solutions to support long-term growth including to plastic packaging; the effect of climate change on Unilever's business; significant changes or deterioration in customer relationships; the recruitment and retention of talented employees; disruptions in our supply chain and distribution; increases or volatility in the cost of raw materials and commodities; the production of safe and high quality products; secure and reliable IT infrastructure; execution of acquisitions, divestitures and business transformation projects; economic, social and political risks and natural disasters; financial risks; failure to meet high and ethical standards; and managing regulatory, tax and legal matters.

 

These forward-looking statements speak only as of the date of this announcement. Except as required by any applicable law or regulation, the Group expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Group's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

 

Further details of potential risks and uncertainties affecting the Group are described in the Group's filings with the London Stock Exchange, Euronext Amsterdam and the US Securities and Exchange Commission, including in the Annual Report on Form 20-F 2018 and the Unilever Annual Report and Accounts 2018. 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMXLLFBKEFBBBX
Date   Source Headline
10th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20266:17 pmRNSCompletion of 2026 Share Buyback
3rd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20265:13 pmRNSTotal Voting Rights
1st Jun 202610:37 amRNSDirector/PDMR Shareholding
1st Jun 202610:29 amRNSTotal Voting Rights
27th May 20267:00 amRNSTransaction in Own Shares
20th May 20267:00 amRNSTransaction in Own Shares
18th May 20264:35 pmRNSDirector/PDMR Shareholding
15th May 20265:45 pmRNSPublication of Information Memorandum
15th May 20265:07 pmRNSPublication of UFN Financial Statements
13th May 20263:54 pmRNSResult of AGM
13th May 20267:00 amRNSTransaction in Own Shares
6th May 20265:49 pmRNSDirector/PDMR Shareholding
6th May 20267:00 amRNSDirector/PDMR Shareholding
6th May 20267:00 amRNSTransaction in Own Shares
1st May 20263:08 pmRNSTotal Voting Rights
30th Apr 20267:01 amRNSShare Buy-Back Programme
30th Apr 20267:00 amRNSQ1 2026 Trading Statement
20th Apr 20261:58 pmRNSDirector/PDMR Shareholding
1st Apr 20264:42 pmRNSTotal Voting Rights
31st Mar 20263:00 pmRNSNotice of AGM
31st Mar 20261:00 pmRNSUnilever Foods and McCormick Agreement
31st Mar 20267:00 amRNSResponse to Media Speculation
20th Mar 20267:00 amRNSResponse to media speculation
6th Mar 20264:21 pmRNSDirector/PDMR Shareholding
6th Mar 20264:09 pmRNSPortfolio Update
2nd Mar 20265:50 pmRNSTotal Voting Rights
2nd Mar 20267:00 amRNSGroup Company Secretary Change
19th Feb 20267:00 amRNSDirector/PDMR Shareholding
16th Feb 20264:38 pmRNSDirector/PDMR Shareholding
16th Feb 20264:26 pmRNSDirector/PDMR Shareholding
13th Feb 20264:57 pmRNSDirector Declaration
12th Feb 20265:11 pmRNSPublication of Supplement
12th Feb 20267:00 amRNS2025 Full Year Results
5th Feb 20264:06 pmRNSNotification of issuance of equity securities
2nd Feb 20264:14 pmRNSTotal Voting Rights
8th Jan 202610:17 amRNSTotal Voting Rights
2nd Jan 20265:21 pmRNSTotal Voting Rights
15th Dec 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 20257:00 amRNSCancellation of Treasury Shares
10th Dec 202511:29 amRNSDirector/PDMR Shareholding
8th Dec 20255:51 pmRNSUpdate on Share Consolidation
8th Dec 20257:00 amRNSCompletion of demerger of Ice Cream Business
5th Dec 20257:00 amRNSDemerger of Unilever’s Ice Cream Business
3rd Dec 20252:50 pmRNSCancellation of Treasury Shares
1st Dec 20256:22 pmRNSTotal Voting Rights
19th Nov 202512:23 pmRNSDirector/PDMR Shareholding
12th Nov 20257:00 amRNSDirector/PDMR Shareholding
4th Nov 20256:21 pmRNSUpdate on Demerger & Share Consolidation Timetable

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.